Genetesis is a medical imaging company leveraging data science and biomagnetism in the fight against cardiovascular disease
Genetesis has raised $17.5M in total funding. The most recent round was Series C. The last funding was announced in October 2022.
Genetesis's investors include TDK Ventures, Mithril Capital Management, CincyTech, JobsOhio, Raptor Group.
Genetesis is headquartered in Mason, United States.
Genetesis is a medical imaging company leveraging data science and biomagnetism in the fight against cardiovascular disease
Genetesis is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Genetesis — Funding & Investors." VCBacked, October 6, 2022, https://www.vcbacked.co/company/genetesis. Accessed September 30, 2026.
VCBacked. (2022). Genetesis — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/genetesis
{{cite web |title=Genetesis — Funding & Investors |url=https://www.vcbacked.co/company/genetesis |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated